The initial indication is reduction of post-operative pain using AmacaThera’s (formerly Hammock Therapeutics) hydrogel in combination with approved anaesthetics. Currently available delivery vehicles are designed with the sole purpose of delivering a drug. AmacaThera’s delivery vehicle has been designed to not only deliver the drug but also to promote healing.